{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:46:06Z","timestamp":1793119566492,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.fertnstert.2024.10.014","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T15:42:39Z","timestamp":1729266159000},"page":"477-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-term safety of controlled ovarian stimulation for fertility preservation before chemotherapy treatment in patients with breast cancer"],"prefix":"10.1016","volume":"123","author":[{"given":"Moran","family":"Shapira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Sella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Safrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evyatar","family":"Villain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Lifshitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Orvieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einav","family":"Gal-Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Meirow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.10.014_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib2","article-title":"Breast cancer incidence among US women aged 20 to 49 years by race, stage, and hormone receptor status","volume":"7","author":"Xu","year":"2024","journal-title":"J Am Med Assoc Netw Open"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib4","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/annonc\/mdq072","article-title":"Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer","volume":"21","author":"Cancello","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-11-2599","article-title":"Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling","volume":"18","author":"Azim","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13058-016-0736-y","article-title":"Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina breast cancer study: a case-control study","volume":"18","author":"Chollet-Hinton","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Paluch-Shimon","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-319-16366-6_2","article-title":"Special issues in younger women with breast cancer","volume":"862","author":"Ganz","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib9","first-page":"285","article-title":"Susceptibility of human breast epithelial cells in\u00a0vitro to hormones and drugs","volume":"28","author":"Calaf","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib10","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in\u00a0vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib12","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/deac145","article-title":"Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols","volume":"37","author":"Balkenende","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/humrep\/deac035","article-title":"Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis","volume":"37","author":"Arecco","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/humrep\/dex027","article-title":"The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review","volume":"32","author":"Rodgers","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.fertnstert.2022.11.020","article-title":"Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer","volume":"119","author":"Sonigo","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cncr.32546","article-title":"Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation","volume":"126","author":"Letourneau","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/humrep\/deaa029","article-title":"Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study","volume":"35","author":"Marklund","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib19","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1002\/cncr.33601","article-title":"The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival","volume":"127","author":"Greer","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-020-06031-4","article-title":"Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation","volume":"186","author":"Moravek","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib21","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1245\/s10434-015-4714-x","article-title":"Neoadjuvant chemotherapy for breast cancer, is practice changing? A population-based review of current surgical trends","volume":"22","author":"Graham","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1200\/GO.22.00008","article-title":"Is fertility preservation feasible and safe with neoadjuvant therapy for breast cancer?","volume":"6","author":"Hershlag","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib23","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1200\/JCO.20.03613","article-title":"Updated standardized definitions for efficacy end points (STEEP) in adjuvant breast cancer clinical trials: STEEP version 2.0","volume":"39","author":"Tolaney","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2023.25463","article-title":"Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study","volume":"331","author":"Lambertini","year":"2024","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejca.2022.06.048","article-title":"Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy","volume":"173","author":"Anderson","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/cncr.33342","article-title":"Pregnancy after breast cancer: results from a prospective cohort of young women with breast cancer","volume":"127","author":"Poorvu","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib28","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/cncr.33596","article-title":"Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors","volume":"127","author":"Sella","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/pon.4927","article-title":"Systematic review of fertility-related psychological distress in cancer patients: Informing on an improved model of care","volume":"28","author":"Logan","year":"2019","journal-title":"Psychooncology"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib30","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1245\/s10434-016-5308-y","article-title":"Fertility in women of reproductive age after breast cancer treatment: practice patterns and outcomes","volume":"23","author":"McCray","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib31","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1245\/s10434-020-08883-y","article-title":"Does use of neoadjuvant chemotherapy affect the decision to pursue fertility preservation options in young women with breast cancer?","volume":"27","author":"Crown","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.23.02292","article-title":"Fertility preservation and assisted reproductive technologies in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy","volume":"42","author":"Azim","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib33","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/humrep\/dex276","article-title":"Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer","volume":"32","author":"Letourneau","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib34","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1245\/s10434-016-5733-y","article-title":"National trends in the use of neoadjuvant chemotherapy for hormone receptor-negative breast cancer: a national cancer data base study","volume":"24","author":"Puig","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib35","doi-asserted-by":"crossref","first-page":"113500","DOI":"10.1016\/j.ejca.2023.113500","article-title":"EUSOMA quality indicators for non-metastatic breast cancer: an update","volume":"198","author":"Rubio","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.clbc.2011.06.001","article-title":"Management of early invasive breast cancer in very young women (<35 years)","volume":"11","author":"Hartmann","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib37","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.014_bib38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V","volume":"34","author":"Colleoni","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224023082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224023082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:36:18Z","timestamp":1772325378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224023082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0015028224023082"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.10.014","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety of controlled ovarian stimulation for fertility preservation before chemotherapy treatment in patients with breast cancer","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}